CUFinder

Dipti Debnath

About Dipti Debnath

Dipti Debnath, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at University of North Texas Health Science Center, specializes in the field of Cancer Biology (PhD Candidate).

His recent articles reflect a diverse array of research interests and contributions to the field:

Developing a nanoparticle platform for selective delivery of the anti-cancer drug MIH 2.4 Bl to breast cancer cells

Using mesoporous silica nanoparticles (MSNs) for delivering the mesoionic compound MIH 2.4 Bl in treating breast cancer

An improved strategy for delivering the mesoionic compound MIH 2.4 Bl utilizing reconstituted high density nanoparticles (rHDL) in treating breast cancer

Role of Environmental Toxicants and Inflammation in Parkinson’s Disease

Developing a stable drug delivery system for the mesoionic compound MIH 2.4 Bl using reconstituted high-density lipoproteins (rHDL) nanoparticles

Fluorescence Characterization and Cellular Localization of the Mesoionic Compound MIH 2.4 Bl

Arsenic Toxicity: Source, Mechanism, Global Health Complication, and Possible Way to Defeat

Lead toxicity: an overview of its pathophysiology and intervention strategies

Dipti Debnath Information

University

Position

___

Citations(all)

93

Citations(since 2020)

88

Cited By

33

hIndex(all)

4

hIndex(since 2020)

4

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Dipti Debnath Skills & Research Interests

Cancer Biology (PhD Candidate)

Top articles of Dipti Debnath

Developing a nanoparticle platform for selective delivery of the anti-cancer drug MIH 2.4 Bl to breast cancer cells

2023

Dipti Debnath
Dipti Debnath

H-Index: 3

Using mesoporous silica nanoparticles (MSNs) for delivering the mesoionic compound MIH 2.4 Bl in treating breast cancer

Cancer Research

2021/7/1

Dipti Debnath
Dipti Debnath

H-Index: 3

Sami Nazzal
Sami Nazzal

H-Index: 23

Rafal Fudala
Rafal Fudala

H-Index: 15

An improved strategy for delivering the mesoionic compound MIH 2.4 Bl utilizing reconstituted high density nanoparticles (rHDL) in treating breast cancer

Cancer Research

2021/7/1

Dipti Debnath
Dipti Debnath

H-Index: 3

Rafal Fudala
Rafal Fudala

H-Index: 15

Role of Environmental Toxicants and Inflammation in Parkinson’s Disease

2021/1/7

Dipti Debnath
Dipti Debnath

H-Index: 3

Developing a stable drug delivery system for the mesoionic compound MIH 2.4 Bl using reconstituted high-density lipoproteins (rHDL) nanoparticles

2021

Dipti Debnath
Dipti Debnath

H-Index: 3

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Fluorescence Characterization and Cellular Localization of the Mesoionic Compound MIH 2.4 Bl

2021

Dipti Debnath
Dipti Debnath

H-Index: 3

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Arsenic Toxicity: Source, Mechanism, Global Health Complication, and Possible Way to Defeat

2020/11/19

Dipti Debnath
Dipti Debnath

H-Index: 3

Lead toxicity: an overview of its pathophysiology and intervention strategies

2020/11/19

Dipti Debnath
Dipti Debnath

H-Index: 3

Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4 Bl in MCF-7 breast cancer cells

2020/6/19

Dipti Debnath
Dipti Debnath

H-Index: 3

Aurea Wischral
Aurea Wischral

H-Index: 10

Epidemiological perspectives of dietary sugars, salts and fats

2020/1/1

Dipti Debnath
Dipti Debnath

H-Index: 3

Sensory drivers of food behavior

2020/1/1

Dipti Debnath
Dipti Debnath

H-Index: 3

See List of Professors in Dipti Debnath University(University of North Texas Health Science Center)